Monoamine oxidase-A (
MAO-A), a key brain
enzyme which metabolizes monoamines, is implicated in the pathophysiology of stress-related illnesses, including
major depressive disorder, addiction, and violent behavior. Chronic stressors and
glucocorticoid-administration typically associate with elevated
MAO-A levels/activity. However, the relationship of shorter stress or
glucocorticoid exposures and
MAO-A levels/activity is not well established. Our objectives are to assess effects of acute stress upon
MAO-A V(T,) an index of
MAO-A density, in human brain and acute
glucocorticoid exposure upon
MAO-A levels in human neuronal and glial cell lines. Twelve healthy, non-smoking participants aged 18-50 underwent [(11)C]
harmine positron emission tomography to measure brain
MAO-A V(T) on two different days: One under acute psychosocial stress (via Trier Social Stress and Montreal Imaging Stress Tasks) and one under a non-stress condition.
MAO-A density (by Western blot) and activity (by [(14)C]-5-HT metabolism and liquid scintillation spectroscopy) were measured in human neuronal and glial cell lines after 4 h exposure to
dexamethasone. We observed a significant reduction in whole-brain
MAO-A binding as reflected by reductions in 10 of 11 brain regions. Acute
dexamethasone exposure in neuronal and glial cells significantly decreased
MAO-A activity and
protein levels. We observed a highly consistent relationship between acute stressors and
glucocorticoid administration and decreased
MAO-A binding, activity and
protein levels. Since
MAO-A metabolizes monoamines, this phenomenon may explain why acute stressors benefit healthy animals even though chronic stress is associated with illness.